Trial · NCT01351753
Results by group24
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 24
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Weight (Percent Change From Baseline) | Metformin | -10.9 | 95% Confidence Interval -14.4 to -7.2 | percentage of weight change | |
| Weight (Percent Change From Baseline) | Metformin + Orlistat | -10.5 | 95% Confidence Interval -14.0 to -6.9 | percentage of weight change | |
| Weight (Percent Change From Baseline) | Metformin + Topiramate | -14.0 | 95% Confidence Interval -17.3 to -10.5 | percentage of weight change | |
| Weight (Percent Change From Baseline) | Topiramate | -12.2 | 95% Confidence Interval -15.6 to -8.6 | percentage of weight change | |
| Weight (Percent Change From Baseline) | Metformin + Topiramate + Orlistat | -16.7 | 95% Confidence Interval -20.3 to -13.0 | percentage of weight change | |
| Weight (Percent Change From Baseline) | Placebo | -6.7 | 95% Confidence Interval -10.5 to -2.7 | percentage of weight change | |
| Office Systolic Blood Pressure (mmHg Change From Baseline) | Metformin | -11.42 | 95% Confidence Interval -21.10 to -1.74 | mmHg | |
| Office Systolic Blood Pressure (mmHg Change From Baseline) | Metformin + Orlistat | -11.41 | 95% Confidence Interval -20.88 to -1.94 | mmHg | |
| Office Systolic Blood Pressure (mmHg Change From Baseline) | Metformin + Topiramate | -10.33 | 95% Confidence Interval -19.52 to -1.14 | mmHg | |
| Office Systolic Blood Pressure (mmHg Change From Baseline) | Topiramate | -8.55 | 95% Confidence Interval -18.53 to 1.44 | mmHg | |
| Office Systolic Blood Pressure (mmHg Change From Baseline) | Metformin + Topiramate + Orlistat | -14.47 | 95% Confidence Interval -24.87 to -4.08 | mmHg | |
| Office Systolic Blood Pressure (mmHg Change From Baseline) | Placebo | -13.26 | 95% Confidence Interval -23.28 to -3.23 | mmHg | |
| Centimeter Change in Waist Circumference | Metformin | -10.62 | 95% Confidence Interval -20.48 to -0.77 | cm change | |
| Centimeter Change in Waist Circumference | Metformin + Orlistat | -9.04 | 95% Confidence Interval -18.78 to -0.78 | cm change | |
| Centimeter Change in Waist Circumference | Metformin + Topiramate | -11.65 | 95% Confidence Interval -21.20 to -2.11 | cm change | |
| Centimeter Change in Waist Circumference | Topiramate | -16.63 | 95% Confidence Interval -26.59 to -6.66 | cm change | |
| Centimeter Change in Waist Circumference | Metformin + Topiramate + Orlistat | -15.76 | 95% Confidence Interval -26.44 to -5.08 | cm change | |
| Centimeter Change in Waist Circumference | Placebo | -10.78 | 95% Confidence Interval -20.79 to -0.78 | cm change | |
| Carotid-femoral Pulse Wave Velocity (PWV)(Change After 6 Months From Baseline) | Metformin | -1.09 | 95% Confidence Interval -2.96 to 0.78 | meters/sec | |
| Carotid-femoral Pulse Wave Velocity (PWV)(Change After 6 Months From Baseline) | Metformin + Orlistat | -1.56 | 95% Confidence Interval -3.47 to 0.36 | meters/sec |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01351753/results